ID   MOCS1_HUMAN             Reviewed;         636 AA.
AC   Q9NZB8; B3KPT7; B4DTP1; O14940; O14941; O75710; Q5J7W0; Q5TCE1;
AC   Q5TCE2; Q5TCE6; Q5TCE9; Q5TCF0; Q5TCF1; Q8N418; Q9NZB7; Q9UEM1;
DT   09-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 3.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Molybdenum cofactor biosynthesis protein 1;
DE   AltName: Full=Cell migration-inducing gene 11 protein;
DE   AltName: Full=Molybdenum cofactor synthesis-step 1 protein A-B;
DE   Includes:
DE     RecName: Full=GTP 3',8-cyclase {ECO:0000305};
DE              EC=4.1.99.22 {ECO:0000250|UniProtKB:P69848};
DE     AltName: Full=Molybdenum cofactor biosynthesis protein A;
DE   Includes:
DE     RecName: Full=Cyclic pyranopterin monophosphate synthase {ECO:0000305};
DE              EC=4.6.1.17 {ECO:0000269|PubMed:23627491};
DE     AltName: Full=Molybdenum cofactor biosynthesis protein C;
GN   Name=MOCS1; ORFNames=MIG11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS MOCS1A; 2 AND 8),
RP   INVOLVEMENT IN MOCODA, AND TISSUE SPECIFICITY.
RX   PubMed=9731530; DOI=10.1038/1706;
RA   Reiss J.P., Cohen N., Dorche C., Mandel H., Mendel R.R.,
RA   Stallmeyer B., Zabot M.-T., Dierks T.;
RT   "Mutations in a polycistronic nuclear gene associated with molybdenum
RT   cofactor deficiency.";
RL   Nat. Genet. 20:51-53(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS MOCS1A AND MOCS1B).
RA   Larin D., Ross B.M., Gilliam T.C.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS MOCS1A AND 7).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 283-636 (ISOFORM 6), AND NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 377-636 (ISOFORM MOCS1B).
RX   PubMed=10917590; DOI=10.1017/S1355838200000182;
RA   Gray T.A., Nicholls R.D.;
RT   "Diverse splicing mechanisms fuse the evolutionarily conserved
RT   bicistronic MOCS1A and MOCS1B open reading frames.";
RL   RNA 6:928-936(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 386-636.
RA   Kim J.W.;
RT   "Identification of a human migration-inducing gene.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, AND ALTERNATIVE SPLICING (ISOFORMS MOCS1A AND MOCS1B).
RX   PubMed=11891227; DOI=10.1074/jbc.M200947200;
RA   Haenzelmann P., Schwarz G., Mendel R.R.;
RT   "Functionality of alternative splice forms of the first enzymes
RT   involved in human molybdenum cofactor biosynthesis.";
RL   J. Biol. Chem. 277:18303-18312(2002).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORMS MOCS1A; 2 AND 3), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12208140; DOI=10.1016/S1096-7192(02)00100-2;
RA   Gross-Hardt S., Reiss J.;
RT   "The bicistronic MOCS1 gene has alternative start codons on two
RT   mutually exclusive exons.";
RL   Mol. Genet. Metab. 76:340-343(2002).
RN   [10]
RP   COFACTOR, CHARACTERIZATION OF IRON-SULFUR CLUSTER-BINDING, AND
RP   MUTAGENESIS OF CYS-80; CYS-84; CYS-87; CYS-312; CYS-315 AND CYS-329.
RX   PubMed=15180982; DOI=10.1074/jbc.M313398200;
RA   Haenzelmann P., Hernandez H.L., Menzel C., Garcia-Serres R.,
RA   Huynh B.H., Johnson M.K., Mendel R.R., Schindelin H.;
RT   "Characterization of MOCS1A, an oxygen-sensitive iron-sulfur protein
RT   involved in human molybdenum cofactor biosynthesis.";
RL   J. Biol. Chem. 279:34721-34732(2004).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-198, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY OF MOCS1B, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=23627491; DOI=10.1021/ja401781t;
RA   Hover B.M., Loksztejn A., Ribeiro A.A., Yokoyama K.;
RT   "Identification of a cyclic nucleotide as a cryptic intermediate in
RT   molybdenum cofactor biosynthesis.";
RL   J. Am. Chem. Soc. 135:7019-7032(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   REVISION OF PTM.
RX   PubMed=25697423; DOI=10.1021/ja512997j;
RA   Hover B.M., Yokoyama K.;
RT   "C-Terminal glycine-gated radical initiation by GTP 3',8-cyclase in
RT   the molybdenum cofactor biosynthesis.";
RL   J. Am. Chem. Soc. 137:3352-3359(2015).
RN   [15]
RP   VARIANTS MOCODA TRP-73; ASP-126; ASP-127; GLN-319 AND GLU-324.
RX   PubMed=9921896; DOI=10.1007/s004390050884;
RA   Reiss J.P., Christensen E., Kurlemann G., Zabot M.-T., Dorche C.;
RT   "Genomic structure and mutational spectrum of the bicistronic MOCS1
RT   gene defective in molybdenum cofactor deficiency type A.";
RL   Hum. Genet. 103:639-644(1998).
RN   [16]
RP   VARIANTS MOCODA TRP-123 AND ARG-324.
RX   PubMed=12754701; DOI=10.1002/humu.10223;
RA   Reiss J., Johnson J.L.;
RT   "Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2,
RT   and GEPH.";
RL   Hum. Mutat. 21:569-576(2003).
RN   [17]
RP   VARIANTS MOCODA TRP-67; GLY-80 AND PHE-84.
RX   PubMed=16021469; DOI=10.1007/s00439-005-1341-9;
RA   Leimkuehler S., Charcosset M., Latour P., Dorche C., Kleppe S.,
RA   Scaglia F., Szymczak I., Schupp P., Hahnewald R., Reiss J.;
RT   "Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2
RT   and in vitro characterization of a MOCS2 mutation that abolishes the
RT   binding ability of molybdopterin synthase.";
RL   Hum. Genet. 117:565-570(2005).
CC   -!- FUNCTION: Isoform MOCS1A and isoform MOCS1B probably form a
CC       complex that catalyzes the conversion of 5'-GTP to cyclic
CC       pyranopterin monophosphate (cPMP). MOCS1A catalyzes the
CC       cyclization of GTP to (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-
CC       triphosphate and MOCS1B catalyzes the subsequent conversion of
CC       (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate to cPMP.
CC       {ECO:0000269|PubMed:11891227}.
CC   -!- CATALYTIC ACTIVITY: GTP + S-adenosyl-L-methionine + reduced
CC       electron acceptor = (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-
CC       triphosphate + 5'-deoxyadenosine + L-methionine + oxidized
CC       electron acceptor. {ECO:0000250|UniProtKB:P69848}.
CC   -!- CATALYTIC ACTIVITY: (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-
CC       triphosphate = cyclic pyranopterin phosphate + diphosphate.
CC       {ECO:0000269|PubMed:23627491}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:15180982};
CC       Note=Binds 2 [4Fe-4S] clusters. Binds 1 [4Fe-4S] cluster
CC       coordinated with 3 cysteines and an exchangeable S-adenosyl-L-
CC       methionine and 1 [4Fe-4S] cluster coordinated with 3 cysteines and
CC       the GTP-derived substrate. {ECO:0000269|PubMed:15180982};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.79 uM for (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-
CC         triphosphate {ECO:0000269|PubMed:23627491};
CC         Note=kcat is 0.092 min(-1) for (8S)-3',8-cyclo-7,8-
CC         dihydroguanosine 5'-triphosphate. {ECO:0000269|PubMed:23627491};
CC   -!- PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.
CC   -!- SUBUNIT: Isoform MOCS1A and isoform MOCS1B probably form a
CC       heterooligomer. {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=So far, the different types of MOCS1A and MOCS1B
CC         isoforms have been investigated independently and several
CC         combinations might be possible.;
CC       Name=MOCS1B; Synonyms=MOCS1B Type-II;
CC         IsoId=Q9NZB8-1; Sequence=Displayed;
CC         Note=Multidomain protein with inactive MOCS1A and active
CC         MOCS1B.;
CC       Name=MOCS1A; Synonyms=MOCS1A Type/Iad;
CC         IsoId=Q9NZB8-5; Sequence=VSP_036826, VSP_036827;
CC       Name=2; Synonyms=MOCS1A Type-Ibcd;
CC         IsoId=Q9NZB8-6; Sequence=VSP_036822, VSP_036826, VSP_036827;
CC       Name=3; Synonyms=MOCS1A Type-Ibd;
CC         IsoId=Q9NZB8-3; Sequence=VSP_036823, VSP_036826, VSP_036827;
CC       Name=4;
CC         IsoId=Q9NZB8-4; Sequence=VSP_036821, VSP_036824, VSP_036825;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=6; Synonyms=MOCS1B Type-III;
CC         IsoId=Q9NZB8-2; Sequence=VSP_007439;
CC         Note=Multidomain protein with inactive MOCS1A and active
CC         MOCS1B.;
CC       Name=7;
CC         IsoId=Q9NZB8-7; Sequence=VSP_036821, VSP_007439;
CC       Name=8;
CC         IsoId=Q9NZB8-8; Sequence=VSP_036822;
CC   -!- TISSUE SPECIFICITY: Isoform MOCS1A and isoform 2 are widely
CC       expressed. {ECO:0000269|PubMed:12208140,
CC       ECO:0000269|PubMed:9731530}.
CC   -!- DISEASE: Molybdenum cofactor deficiency, complementation group A
CC       (MOCODA) [MIM:252150]: An autosomal recessive metabolic disorder
CC       leading to the pleiotropic loss of molybdoenzyme activities. It is
CC       clinically characterized by onset in infancy of poor feeding,
CC       intractable seizures, severe psychomotor retardation, and death in
CC       early childhood in most patients. {ECO:0000269|PubMed:12754701,
CC       ECO:0000269|PubMed:16021469, ECO:0000269|PubMed:9731530,
CC       ECO:0000269|PubMed:9921896}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The MOCS1 locus has initially been reported to
CC       produce MOCS1A and MOCS1B from non-overlapping reading frames
CC       within a bicistronic transcript. However, only isoform MOCS1A
CC       seems to be translated from the bicistronic transcript. Isoform
CC       MOCS1B seems to be translated from a monocistronic mRNA that is
CC       derived by alternative splicing.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the MoaC family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the radical SAM
CC       superfamily. MoaA family. {ECO:0000305}.
CC   -!- CAUTION: The C-terminus of MOCS1A was previously believed to be
CC       thiocarboxylated, but it is now known not to be the case.
CC       {ECO:0000305|PubMed:25697423}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB87524.1; Type=Miscellaneous discrepancy; Note=Alternative splicing in the MOCS1A-MOCS1B joining region.; Evidence={ECO:0000305};
CC       Sequence=AAS00489.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAC44526.1; Type=Miscellaneous discrepancy; Note=Alternative splicing in the MOCS1A-MOCS1B joining region.; Evidence={ECO:0000305};
CC       Sequence=CAI20007.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI20012.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI20013.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ224328; CAA11897.1; -; mRNA.
DR   EMBL; AJ224328; CAA11898.1; -; mRNA.
DR   EMBL; AJ404969; CAC44526.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ293577; CAC44527.1; -; Genomic_DNA.
DR   EMBL; AJ293578; CAC44527.1; JOINED; Genomic_DNA.
DR   EMBL; AJ293579; CAC44527.1; JOINED; Genomic_DNA.
DR   EMBL; AF034374; AAB87523.1; -; mRNA.
DR   EMBL; AF034374; AAB87524.1; ALT_SEQ; mRNA.
DR   EMBL; AK300300; BAG62053.1; -; mRNA.
DR   EMBL; AK056740; BAG51799.1; -; mRNA.
DR   EMBL; AL136089; CAI20007.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL136089; CAI20011.1; -; Genomic_DNA.
DR   EMBL; AL136089; CAI20012.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL136089; CAI20013.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL136089; CAI20014.1; -; Genomic_DNA.
DR   EMBL; AL136089; CAI20015.1; -; Genomic_DNA.
DR   EMBL; BC036839; AAH36839.1; -; mRNA.
DR   EMBL; AF214022; AAF67857.1; -; mRNA.
DR   EMBL; AF214023; AAF67858.1; -; mRNA.
DR   EMBL; AY423726; AAS00489.1; ALT_INIT; mRNA.
DR   CCDS; CCDS43460.1; -. [Q9NZB8-5]
DR   CCDS; CCDS4846.1; -. [Q9NZB8-6]
DR   RefSeq; NP_001068566.1; NM_001075098.3. [Q9NZB8-5]
DR   RefSeq; NP_005934.2; NM_005943.5. [Q9NZB8-6]
DR   RefSeq; XP_011512934.1; XM_011514632.2. [Q9NZB8-1]
DR   RefSeq; XP_011512935.1; XM_011514633.2. [Q9NZB8-2]
DR   UniGene; Hs.357128; -.
DR   UniGene; Hs.718492; -.
DR   ProteinModelPortal; Q9NZB8; -.
DR   SMR; Q9NZB8; -.
DR   BioGrid; 110480; 11.
DR   IntAct; Q9NZB8; 1.
DR   STRING; 9606.ENSP00000362282; -.
DR   iPTMnet; Q9NZB8; -.
DR   PhosphoSitePlus; Q9NZB8; -.
DR   BioMuta; MOCS1; -.
DR   DMDM; 30913216; -.
DR   MaxQB; Q9NZB8; -.
DR   PaxDb; Q9NZB8; -.
DR   PeptideAtlas; Q9NZB8; -.
DR   PRIDE; Q9NZB8; -.
DR   DNASU; 4337; -.
DR   Ensembl; ENST00000340692; ENSP00000344794; ENSG00000124615. [Q9NZB8-1]
DR   Ensembl; ENST00000373181; ENSP00000362277; ENSG00000124615. [Q9NZB8-4]
DR   Ensembl; ENST00000373186; ENSP00000362282; ENSG00000124615. [Q9NZB8-6]
DR   Ensembl; ENST00000373188; ENSP00000362284; ENSG00000124615. [Q9NZB8-5]
DR   Ensembl; ENST00000373195; ENSP00000362291; ENSG00000124615. [Q9NZB8-7]
DR   Ensembl; ENST00000425303; ENSP00000416478; ENSG00000124615. [Q9NZB8-8]
DR   Ensembl; ENST00000432280; ENSP00000410809; ENSG00000124615. [Q9NZB8-3]
DR   GeneID; 4337; -.
DR   KEGG; hsa:4337; -.
DR   UCSC; uc003opa.4; human. [Q9NZB8-1]
DR   CTD; 4337; -.
DR   DisGeNET; 4337; -.
DR   GeneCards; MOCS1; -.
DR   HGNC; HGNC:7190; MOCS1.
DR   HPA; HPA045783; -.
DR   HPA; HPA058177; -.
DR   HPA; HPA075505; -.
DR   MalaCards; MOCS1; -.
DR   MIM; 252150; phenotype.
DR   MIM; 603707; gene.
DR   neXtProt; NX_Q9NZB8; -.
DR   OpenTargets; ENSG00000124615; -.
DR   Orphanet; 308386; Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A.
DR   PharmGKB; PA30900; -.
DR   eggNOG; KOG2876; Eukaryota.
DR   eggNOG; COG2896; LUCA.
DR   GeneTree; ENSGT00390000016567; -.
DR   InParanoid; Q9NZB8; -.
DR   KO; K20967; -.
DR   OMA; GWIHQIR; -.
DR   OrthoDB; EOG091G0HQS; -.
DR   PhylomeDB; Q9NZB8; -.
DR   TreeFam; TF300424; -.
DR   Reactome; R-HSA-947581; Molybdenum cofactor biosynthesis.
DR   UniPathway; UPA00344; -.
DR   GeneWiki; MOCS1; -.
DR   GenomeRNAi; 4337; -.
DR   PRO; PR:Q9NZB8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000124615; -.
DR   CleanEx; HS_MOCS1; -.
DR   ExpressionAtlas; Q9NZB8; baseline and differential.
DR   Genevisible; Q9NZB8; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0019008; C:molybdopterin synthase complex; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0061799; F:cyclic pyranopterin monophosphate synthase activity; IMP:MGI.
DR   GO; GO:0061798; F:GTP 3',8'-cyclase activity; IMP:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome.
DR   CDD; cd01420; MoaC_PE; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   Gene3D; 3.30.70.640; -; 1.
DR   HAMAP; MF_01225_B; MoaA_B; 1.
DR   HAMAP; MF_01224_B; MoaC_B; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR006638; Elp3/MiaB/NifB.
DR   InterPro; IPR034481; Main_SPASM_domain-containing.
DR   InterPro; IPR023045; Mo_CF_biosynth-C.
DR   InterPro; IPR013483; MoaA.
DR   InterPro; IPR000385; MoaA_NifB_PqqE_Fe-S-bd_CS.
DR   InterPro; IPR010505; Mob_synth_C.
DR   InterPro; IPR002820; Mopterin_CF_biosynth-C_dom.
DR   InterPro; IPR007197; rSAM.
DR   Pfam; PF01967; MoaC; 1.
DR   Pfam; PF06463; Mob_synth_C; 1.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   SFLD; SFLDG01383; cyclic_pyranopterin_phosphate_; 1.
DR   SFLD; SFLDG01386; main_SPASM_domain-containing; 1.
DR   SMART; SM00729; Elp3; 1.
DR   SUPFAM; SSF55040; SSF55040; 1.
DR   TIGRFAMs; TIGR02666; moaA; 1.
DR   TIGRFAMs; TIGR00581; moaC; 1.
DR   PROSITE; PS01305; MOAA_NIFB_PQQE; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; GTP-binding; Iron; Iron-sulfur; Lyase;
KW   Metal-binding; Molybdenum cofactor biosynthesis; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   S-adenosyl-L-methionine.
FT   CHAIN         1    636       Molybdenum cofactor biosynthesis protein
FT                                1.
FT                                /FTId=PRO_0000097870.
FT   REGION        1    383       Molybdenum cofactor biosynthesis protein
FT                                A.
FT   REGION      317    319       GTP binding. {ECO:0000250}.
FT   REGION      414    636       Molybdenum cofactor biosynthesis protein
FT                                C.
FT   ACT_SITE    606    606       For molybdenum cofactor biosynthesis
FT                                protein C activity. {ECO:0000255}.
FT   METAL        80     80       Iron-sulfur 1 (4Fe-4S-S-AdoMet).
FT                                {ECO:0000305}.
FT   METAL        84     84       Iron-sulfur 1 (4Fe-4S-S-AdoMet).
FT                                {ECO:0000305}.
FT   METAL        87     87       Iron-sulfur 1 (4Fe-4S-S-AdoMet).
FT                                {ECO:0000305}.
FT   METAL       312    312       Iron-sulfur 2 (4Fe-4S-substrate).
FT                                {ECO:0000305}.
FT   METAL       315    315       Iron-sulfur 2 (4Fe-4S-substrate).
FT                                {ECO:0000305}.
FT   METAL       329    329       Iron-sulfur 2 (4Fe-4S-substrate).
FT                                {ECO:0000305}.
FT   BINDING      73     73       GTP. {ECO:0000250}.
FT   BINDING      86     86       S-adenosyl-L-methionine. {ECO:0000250}.
FT   BINDING     123    123       GTP. {ECO:0000250}.
FT   BINDING     127    127       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     154    154       GTP. {ECO:0000250}.
FT   BINDING     178    178       S-adenosyl-L-methionine. {ECO:0000250}.
FT   BINDING     215    215       GTP. {ECO:0000250}.
FT   BINDING     249    249       S-adenosyl-L-methionine; via amide
FT                                nitrogen and carbonyl oxygen.
FT                                {ECO:0000250}.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     198    198       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     528    528       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q5RKZ7}.
FT   VAR_SEQ       1     87       Missing (in isoform 4 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036821.
FT   VAR_SEQ       1     41       MAARPLSRMLRRLLRSSARSCSSGAPVTQPCPGESARAASE
FT                                -> MWKSWKLRTDVRVREGAGGSPCASSQPGSRGPCFLPGL
FT                                SSQ (in isoform 2 and isoform 8).
FT                                {ECO:0000303|PubMed:9731530}.
FT                                /FTId=VSP_036822.
FT   VAR_SEQ       1     41       MAARPLSRMLRRLLRSSARSCSSGAPVTQPCPGESARAASE
FT                                -> MWKSWKLRTDVR (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_036823.
FT   VAR_SEQ     368    383       Missing (in isoform 6 and isoform 7).
FT                                {ECO:0000303|PubMed:10917590,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_007439.
FT   VAR_SEQ     368    368       G -> E (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036824.
FT   VAR_SEQ     369    636       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036825.
FT   VAR_SEQ     384    385       EL -> GG (in isoform MOCS1A, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9731530,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_036826.
FT   VAR_SEQ     386    636       Missing (in isoform MOCS1A, isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9731530,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_036827.
FT   VARIANT      67     67       R -> W (in MOCODA; dbSNP:rs754441164).
FT                                {ECO:0000269|PubMed:16021469}.
FT                                /FTId=VAR_054823.
FT   VARIANT      73     73       R -> W (in MOCODA; dbSNP:rs104893970).
FT                                {ECO:0000269|PubMed:9921896}.
FT                                /FTId=VAR_015658.
FT   VARIANT      80     80       C -> G (in MOCODA; dbSNP:rs151141411).
FT                                {ECO:0000269|PubMed:16021469}.
FT                                /FTId=VAR_054824.
FT   VARIANT      84     84       C -> F (in MOCODA).
FT                                {ECO:0000269|PubMed:16021469}.
FT                                /FTId=VAR_054825.
FT   VARIANT     123    123       R -> W (in MOCODA; dbSNP:rs779592342).
FT                                {ECO:0000269|PubMed:12754701}.
FT                                /FTId=VAR_054826.
FT   VARIANT     126    126       G -> D (in MOCODA; dbSNP:rs372246702).
FT                                {ECO:0000269|PubMed:9921896}.
FT                                /FTId=VAR_015659.
FT   VARIANT     127    127       G -> D (in MOCODA).
FT                                {ECO:0000269|PubMed:9921896}.
FT                                /FTId=VAR_015660.
FT   VARIANT     319    319       R -> Q (in MOCODA; dbSNP:rs104893969).
FT                                {ECO:0000269|PubMed:9921896}.
FT                                /FTId=VAR_015661.
FT   VARIANT     324    324       G -> E (in MOCODA).
FT                                {ECO:0000269|PubMed:9921896}.
FT                                /FTId=VAR_015662.
FT   VARIANT     324    324       G -> R (in MOCODA; dbSNP:rs762253951).
FT                                {ECO:0000269|PubMed:12754701}.
FT                                /FTId=VAR_054827.
FT   VARIANT     390    390       P -> H (in dbSNP:rs11969769).
FT                                /FTId=VAR_056131.
FT   VARIANT     452    452       R -> L (in dbSNP:rs11969206).
FT                                /FTId=VAR_061346.
FT   MUTAGEN      80     80       C->S: Impairs precursor Z synthesis.
FT                                {ECO:0000269|PubMed:15180982}.
FT   MUTAGEN      84     84       C->S: Impairs precursor Z synthesis.
FT                                {ECO:0000269|PubMed:15180982}.
FT   MUTAGEN      87     87       C->S: Impairs precursor Z synthesis.
FT                                {ECO:0000269|PubMed:15180982}.
FT   MUTAGEN     312    312       C->S: Impairs precursor Z synthesis.
FT                                {ECO:0000269|PubMed:15180982}.
FT   MUTAGEN     315    315       C->S: Impairs precursor Z synthesis.
FT                                {ECO:0000269|PubMed:15180982}.
FT   MUTAGEN     329    329       C->S: Impairs precursor Z synthesis.
FT                                {ECO:0000269|PubMed:15180982}.
FT   CONFLICT    233    233       A -> V (in Ref. 3; BAG51799/BAG62053).
FT                                {ECO:0000305}.
FT   CONFLICT    239    239       L -> H (in Ref. 2; AAB87523).
FT                                {ECO:0000305}.
FT   CONFLICT    421    421       A -> G (in Ref. 3; BAG51799).
FT                                {ECO:0000305}.
SQ   SEQUENCE   636 AA;  70105 MW;  6774A563BAC42120 CRC64;
     MAARPLSRML RRLLRSSARS CSSGAPVTQP CPGESARAAS EEVSRRRQFL REHAAPFSAF
     LTDSFGRQHS YLRISLTEKC NLRCQYCMPE EGVPLTPKAN LLTTEEILTL ARLFVKEGID
     KIRLTGGEPL IRPDVVDIVA QLQRLEGLRT IGVTTNGINL ARLLPQLQKA GLSAINISLD
     TLVPAKFEFI VRRKGFHKVM EGIHKAIELG YNPVKVNCVV MRGLNEDELL DFAALTEGLP
     LDVRFIEYMP FDGNKWNFKK MVSYKEMLDT VRQQWPELEK VPEEESSTAK AFKIPGFQGQ
     ISFITSMSEH FCGTCNRLRI TADGNLKVCL FGNSEVSLRD HLRAGASEQE LLRIIGAAVG
     RKKRQHAGMF SISQMKNRPM ILIELFLMFP NSPPANPSIF SWDPLHVQGL RPRMSFSSQV
     ATLWKGCRVP QTPPLAQQRL GSGSFQRHYT SRADSDANSK CLSPGSWASA APSGPQLTSE
     QLTHVDSEGR AAMVDVGRKP DTERVAVASA VVLLGPVAFK LVQQNQLKKG DALVVAQLAG
     VQAAKVTSQL IPLCHHVALS HIQVQLELDS TRHAVKIQAS CRARGPTGVE MEALTSAAVA
     ALTLYDMCKA VSRDIVLEEI KLISKTGGQR GDFHRA
//
